BlaidsX Neuro vs RxEars Rxi

The BlaidsX Neuro is a mid-priced behind-the-ear OTC hearing aid priced at $799, earning a B grade with a SoundScore of 3.4/5 in our lab testing. This places it in the top 68% of OTC hearing aids tested, though it falls below the category average of 3.71. In our testing, the BlaidsX Neuro showed notable strengths in speech clarity for quiet environments, scoring 0.54 points above the category average. Feedback handling was excellent at 5.0/5, ranking among the best we've measured and 0.46 points above average. These results suggest the device may work well for conversations in calm settings where background noise isn't a factor. However, the device showed significant limitations in other areas. Speech in noise performance scored low at 1.0/5, falling 0.48 points below the category average—a concern for users who need help in challenging listening environments. Own-voice comfort also scored below average at 1.7/5, and music streaming scored 0.0/5, making it unsuitable for those who want to stream audio content. At this price point, buyers face strong competition. Devices like the Sony CRE-E10 and Lexie B2 Plus offer substantially higher overall scores in the same price range. The BlaidsX Neuro may suit users who primarily need help with face-to-face conversation in quiet spaces and don't require streaming capabilities, but those seeking versatile performance should consider alternatives.

The RxEars Rxi is a budget-priced prescription hearing aid in an invisible-in-ear style, earning an A grade with a SoundScore of 4.1/5 in our lab testing. At $499, it represents one of the most affordable options in the prescription hearing aid category while still delivering solid overall performance. Speech clarity is a notable strength for this device. In quiet listening environments, the Rxi scores 4.3/5, which is 0.97 points above the category average—a strong result that should benefit users in conversational settings at home or in calm environments. Speech understanding in noisy conditions scores 2.1/5, slightly above the category average by 0.16 points, though this remains mixed in absolute terms and may present challenges in demanding acoustic situations like busy restaurants. Feedback handling is excellent at 4.7/5, essentially matching the category average and indicating reliable stability during daily wear. However, the Rxi shows notable limitations in other areas. Own-voice comfort scores 1.6/5, falling 1.15 points below the category average, which may result in a hollow or boomy perception of your own voice. Music streaming is not supported, scoring 0.0/5—a significant gap of 2.64 points below category average that buyers should consider if streaming audio matters to them. The RxEars Rxi is best suited for budget-conscious consumers who prioritize speech clarity in quieter environments and don't require streaming capabilities. Its invisible form factor and disposable battery design offer convenience, though those seeking better own-voice comfort or music features should explore alternatives.